Semaglutide vs. GLP-1: Clearing Up the Confusion for Good

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on peptides and GLP-1 pathways. Browse all Peptides & GLP-1 education

"Semaglutide" and "GLP-1" get used as if they mean the same thing. They do not. One is a naturally occurring hormone and the class of medications built to mimic it; the other is a single specific molecule within that class. Sorting out the terminology is the fastest way to understand what these medications actually are — and why the marketing shorthand causes so much confusion.

What "GLP-1" Actually Means

GLP-1 stands for glucagon-like peptide-1, a hormone your gut releases after eating. It signals the pancreas to release insulin, slows how quickly the stomach empties, and acts on appetite centers in the brain to promote fullness. "GLP-1 medications," more precisely called GLP-1 receptor agonists, are drugs engineered to activate that same receptor and extend those effects far beyond the few minutes the natural hormone lasts.

So "GLP-1" is a category, not a product. Several different molecules belong to it, and they are not interchangeable.

Where Semaglutide Fits

Semaglutide is one specific GLP-1 receptor agonist. It is the active ingredient marketed under the brand names Ozempic and Rybelsus for type 2 diabetes and Wegovy for chronic weight management. The FDA approved semaglutide for weight management in adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition. In the STEP 1 trial, participants lost roughly 15% of body weight on average over 68 weeks alongside lifestyle changes.

Calling semaglutide "a GLP-1" is accurate. Calling every GLP-1 "semaglutide" is not — that is where the confusion starts.

Other Molecules in the GLP-1 Space

Semaglutide has company. Tirzepatide, marketed as Mounjaro and Zepbound, activates the GLP-1 receptor and the GIP receptor, making it a dual agonist rather than a pure GLP-1 agonist. Older agents like liraglutide and dulaglutide sit in the same broad family with different durations and dosing schedules. Each molecule engages the pathway a little differently, which is why they are studied and labeled separately rather than lumped together.

Why the Distinction Matters

The class label tells you the mechanism; the molecule name tells you the specifics — the approved indications, the trial data, the side-effect profile, and the labeling. When someone says they are "on a GLP-1," that describes a pathway, not a prescription. Which specific agent, in what form, for what indication, is a decision only a licensed provider can make. This article does not offer dosing, titration, or how-to-obtain guidance for any of these medications.

The Genetic Variable: GLP1R

Every one of these medications ultimately acts on the same target: the GLP-1 receptor, encoded by the gene GLP1R. Common variants in, such as rs6923761 (a Gly168Ser substitution) and rs10305420, have been studied for their association with differences in receptor signaling and insulin secretion. Research suggests these variants shape the baseline biology of the GLP-1 pathway that all GLP-1 receptor agonists engage.

Important boundary: this is pathway-level insight, not drug prediction. Knowing your GLP1R profile does not tell you whether a specific medication will work for you, and no responsible test claims otherwise. It describes the receptor biology you start from, not the outcome of any protocol.

PlexusDx offers semaglutide through its Weight Management Protocols, available in both injection and oral formats and dispensed through licensed 503A compounding pharmacies. What sets the PlexusDx approach apart is the upstream genetic context. Before starting any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including variants in genes like GLP1R that shape your baseline GLP-1 receptor biology. Knowing that genetic profile alongside the protocol itself is the test-before-you-invest approach, turning guesswork into an informed conversation with your healthcare provider.

Frequently Asked Questions: Semaglutide vs GLP-1

Is semaglutide the same as GLP-1?

No. GLP-1 is a natural gut hormone and the name of the medication class that mimics it. Semaglutide is one specific GLP-1 receptor agonist within that class, sold as Ozempic, Wegovy, and Rybelsus. Every semaglutide is a GLP-1, but not every GLP-1 is semaglutide.

How is semaglutide different from tirzepatide?

Semaglutide activates only the GLP-1 receptor, while tirzepatide activates both the GLP-1 and GIP receptors as a dual agonist. They were studied in separate trials with different populations and endpoints, so their labeling and effects differ. Both engage the shared GLP-1 pathway your GLP1R gene helps shape.

Does genetic testing predict semaglutide response?

No. The Precision Peptide Genetic Test does not predict response to semaglutide or any medication. It analyzes pathway-level variants, such as those in that research links to baseline GLP-1 receptor biology. That genetic context informs a conversation with your provider — it does not forecast an outcome.

Which GLP-1 does PlexusDx offer?

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, in both injection and oral formats, dispensed by licensed 503A compounding pharmacies. A qualified healthcare provider determines whether any protocol is appropriate. The genetic test is a separate upstream tool for understanding your pathway biology first.

Explore the options: see the PlexusDx Weight Management Protocols for semaglutide and tirzepatide. Or start upstream and take the Precision Peptide Genetic Test to understand your GLP-1 pathway before you invest.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

This article is educational. PlexusDx offers semaglutide through its Weight Management Protocols — this article covers the mechanism, evidence, and genetic context that informs any decision to use it. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.